» Authors » Erik Skaaheim Haug

Erik Skaaheim Haug

Explore the profile of Erik Skaaheim Haug including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 267
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kjobli E, Haug E, Salvesen O, Arstad C, Bergesen A, Brennhovd B, et al.
Cancers (Basel) . 2025 Feb; 17(3). PMID: 39941772
: Pelvic lymph node dissection during standard radical cystectomy (stdRC) for muscle invasive bladder cancer is performed as separate templates. In the modernized en bloc radical cystectomy (mEbRC), the bladder...
2.
Gustavsen E, Haug E, Haukland E, Heimdal R, Stensland E, Myklebust T, et al.
Res Health Serv Reg . 2024 Aug; 3(1):8. PMID: 39177854
Purpose: The aim of this study was to examine geographic and socioeconomic variation in curative treatment and choice of treatment modality among elderly prostate cancer (PCa) patients. Methods: This register-based...
3.
Jaderling F, Bergman M, Engel J, Mortezavi A, Picker W, Haug E, et al.
BMC Urol . 2024 Aug; 24(1):168. PMID: 39112967
Background: Magnetic  resonance imaging (MRI) followed by targeted biopsy (TBx) is utilized for prostate cancer (PCa) detection. However, the value of adding systematic biopsies (SBx) to targeted biopsy procedures (combined...
4.
Cyll K, Haug E, Pradhan M, Vlatkovic L, Carlsen B, Loffeler S, et al.
Br J Cancer . 2024 Jul; 131(5):895-904. PMID: 38961192
Background: Current risk stratification tools for prostate cancer patients under active surveillance (AS) may inadequately identify those needing treatment. We investigated DNA ploidy and PTEN as potential biomarkers to predict...
5.
Oedorf K, Haug E, Liedberg F, Jarvinen R, Gudjonsson S, Bostrom P, et al.
BMC Urol . 2024 Jun; 24(1):132. PMID: 38914985
Background: Upper tract urothelial carcinoma (UTUC) is a rare malignancy, with typically only few new cases annually per urological department. Adherence to European association of urology (EAU) guidelines on UTUC...
6.
Nilsson R, Naess-Andresen T, Myklebust T, Bernklev T, Kersten H, Haug E
BJUI Compass . 2024 May; 5(5):502-511. PMID: 38751947
Objectives: To prospectively analyse the associations between pre-diagnostic levels of anxiety and depression and patient-reported urinary and sexual adverse effects after radical prostatectomy in a population-based setting. Patients And Methods:...
7.
Loffeler S, Bertilsson H, Muller C, Aas K, Haugnes H, Aksnessaether B, et al.
BJU Int . 2024 Mar; 133(6):680-689. PMID: 38469686
Background: Older men (aged ≥75 years) with high risk, non-metastatic prostate cancer (PCa) are increasingly treated with curative therapy (surgery or radiotherapy). However, it is unclear if curative therapy prolongs...
8.
Otrebski Nilsson M, Aas K, Myklebust T, Gjelsvik Y, Haug E, Fossa S, et al.
Scand J Urol . 2023 Dec; 58:133-140. PMID: 38116675
In comparable men with non-metastatic prostate cancer, radical prostatectomy (RP), radiotherapy (RAD) and active surveillance (AS) are treatment options with similar survival rates, but different side-effects. Healthcare professionals consider pretreatment...
9.
Haug E, Myklebust T, Juliebo-Jones P, Reisaeter L, Aas K, Berg A, et al.
BJUI Compass . 2023 Apr; 4(3):331-338. PMID: 37025477
Objectives: The aim of this study is to evaluate the 2015 introduction of prebiopsy magnetic resonance imaging of the prostate (MRI-P) as the standard of care for diagnosing prostate cancer...
10.
Hofmann B, Haug E, Andersen E, Kjelle E
J Eval Clin Pract . 2022 Nov; 29(6):893-902. PMID: 36374190
Rationale: Increased attention to cancer care has instigated altered systems for screening, diagnosis, and management of various types of cancer, such as in the prostate. While such systems very likely...